Conference Call with Dr. Lal Pathlabs Management and Analysts on Q4FY24 Performance and Outlook. Listen to the full earnings transcript.
Healthcare Services company Dr. Lal PathLabs announced Q4FY24 results: Revenue increased by 11.1% in Q4FY24 EBITDA increased by 25.1% with a margin of 26.5% PAT increased by 50.8% with a margin for of 15.7% Result PDF